One stock that's starting to trend within range of triggering a major breakout trade is Stereotaxis (STXS), which designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. This stock has been trending hot so far in 2013, with shares up sharply by 50%.
If you take a look at the chart for Stereotaxis, youll notice that this stock recently formed a major bottoming chart pattern, with buyers coming in to support the shares at $3.10, $3.23 and $3.11 over the last three months. This stock has now started to trend back above its 50-day moving average of $3.64 a share and it's quickly moving within range of triggering a major breakout trade above some near-term overhead resistance levels.
Traders should now look for long-biased trades in STXS if it manages to break out above some near-term overhead resistance levels at $4.10 to $4.30 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 1.44 million shares. If that breakout hits soon, then STXS will set up to re-test or possibly take out its next major overhead resistance level at $6.24 a share. Any high-volume move above that level will then give STXS a chance to re-fill some of its previous gap down zone from August that started near $10 a share.
Traders can look to buy STXS off any weakness to anticipate that breakout and simply use a stop that sits right around some near-term support at $3.30 a share. One can also buy STXS off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.